Several experimental evidence indicate the involvement of gelatinases A (MMP-2) and B (MMP-9) in the pathogenesis of HIV-associated dementia (HAD) [5], Multiple Sclerosis (MS) [6–8] and cancer progression [9]. This evidence concerns the gene MMP2 and myeloid sarcoma.